IPO Boutique

Kyverna Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Kyverna Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Kyverna Therapeutics Inc.KYTX -
NASDAQ
$20.00-$21.00 $22.00 $34.2514.5 million2/8/2024
JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo
Co-Manager(s):
Health Care
Filing(s):

Filed 2024-01-16
Terms Added 2024-02-01
Amended Prospectus 2024-02-06



Kyverna Therapeutics Inc. Quote & Chart - Click for current quote - KYTX

About Kyverna Therapeutics Inc. (adapted from Kyverna Therapeutics Inc. prospectus):
They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "KYTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved